SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 646-657, abril 2022. ilus
Article
en En
| IBECS
| ID: ibc-203769
Biblioteca responsable:
ES1.1
Ubicación: ES15.1 - BNCS
ABSTRACT
The management of localized rectal cancer requires a multidisciplinary approach to optimize outcomes, reduce morbidity and prevent under or overtreatments. While early stages may obtain benefit of local resections without any additional therapies, locally advanced rectal cancer becomes a challenge defining the better sequential strategy of surgery, radiotherapy and chemotherapy. The latest results of international phase III studies have positioned the total neoadjuvant therapy as a potential new standard of care in high risk rectal cancers, however, the best schedule is still not well defined.
Palabras clave
Texto completo:
1
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Recto
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Terapia Neoadyuvante
/
Quimioradioterapia
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Año:
2022
Tipo del documento:
Article